Literature DB >> 21173183

Efflux-mediated antibiotic resistance in Acinetobacter spp.

Sébastien Coyne1, Patrice Courvalin, Bruno Périchon.   

Abstract

Among Acinetobacter spp., A. baumannii is the most frequently implicated in nosocomial infections, in particular in intensive care units. It was initially thought that multidrug resistance (MDR) in this species was due mainly to horizontal acquisition of resistance genes. However, it has recently become obvious that increased expression of chromosomal genes for efflux systems plays a major role in MDR. Among the five superfamilies of pumps, resistance-nodulation-division (RND) systems are the most prevalent in multiply resistant A. baumannii. RND pumps typically exhibit a wide substrate range that can include antibiotics, dyes, biocides, detergents, and antiseptics. Overexpression of AdeABC, secondary to mutations in the adeRS genes encoding a two-component regulatory system, constitutes a major mechanism of multiresistance in A. baumannii. AdeIJK, intrinsic to this species, is responsible for natural resistance, but since overexpression above a certain threshold is toxic for the host, its contribution to acquired resistance is minimal. The recently described AdeFGH, probably regulated by a LysR-type transcriptional regulator, also confers multidrug resistance when overexpressed. Non-RND efflux systems, such as CraA, AmvA, AbeM, and AbeS, have also been characterized for A. baumannii, as have AdeXYZ and AdeDE for other Acinetobacter spp. Finally, acquired narrow-spectrum efflux pumps, such as the major facilitator superfamily (MFS) members TetA, TetB, CmlA, and FloR and the small multidrug resistance (SMR) member QacE in Acinetobacter spp., have been detected and are mainly encoded by mobile genetic elements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173183      PMCID: PMC3067115          DOI: 10.1128/AAC.01388-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  67 in total

Review 1.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 2.  Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

Authors:  Jordi Vila; Sara Martí; Javier Sánchez-Céspedes
Journal:  J Antimicrob Chemother       Date:  2007-02-26       Impact factor: 5.790

Review 3.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii.

Authors:  Jennifer K Mak; Mi-Jurng Kim; Jeanette Pham; John Tapsall; Peter A White
Journal:  J Antimicrob Chemother       Date:  2008-11-06       Impact factor: 5.790

5.  Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains.

Authors:  Alexandr Nemec; Martina Maixnerová; Tanny J K van der Reijden; Peterhans J van den Broek; Lenie Dijkshoorn
Journal:  J Antimicrob Chemother       Date:  2007-06-26       Impact factor: 5.790

6.  An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.

Authors:  Wensi S Hu; Shu-Man Yao; Chang-Phone Fung; Yi-Ping Hsieh; Chang-Pan Liu; Jing-Fang Lin
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

7.  Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.

Authors:  Anton Y Peleg; Jennifer Adams; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

Review 8.  Mechanisms of RND multidrug efflux pumps.

Authors:  Hiroshi Nikaido; Yumiko Takatsuka
Journal:  Biochim Biophys Acta       Date:  2008-11-03

9.  ATPase genes of diverse multidrug-resistant Acinetobacter baumannii isolates frequently harbour integrated DNA.

Authors:  Farha Shaikh; Richard P Spence; Katrina Levi; Hong-Yu Ou; Zixin Deng; Kevin J Towner; Kumar Rajakumar
Journal:  J Antimicrob Chemother       Date:  2008-11-19       Impact factor: 5.790

10.  Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital.

Authors:  Kevin S Akers; Katrin Mende; Heather C Yun; Duane R Hospenthal; Miriam L Beckius; Xin Yu; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

View more
  161 in total

Review 1.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

2.  Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.

Authors:  Rajbharan Yadav; Cornelia B Landersdorfer; Roger L Nation; John D Boyce; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.

Authors:  Roberta F Ventura; Anna Clara M Galdino; Livia Viganor; Ricardo P Schuenck; Michael Devereux; Malachy McCann; André L S Santos; Ana Paula F Nunes
Journal:  Braz J Microbiol       Date:  2020-07-31       Impact factor: 2.476

5.  Effect of Sodium Chloride on Surface-Associated Motility of Acinetobacter baumannii and the Role of AdeRS Two-Component System.

Authors:  P Malaka De Silva; Ayush Kumar
Journal:  J Membr Biol       Date:  2017-09-02       Impact factor: 1.843

Review 6.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

7.  RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.

Authors:  Eun-Jeong Yoon; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

8.  In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Kirk Nelson; Debora Rubio-Aparicio; Ruslan Tsivkovski; Dongxu Sun; Maxim Totrov; Michael Dudley; Olga Lomovskaya
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

9.  AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii.

Authors:  J-R Sun; C-L Perng; J-C Lin; Y-S Yang; M-C Chan; T-Y Chang; F-M Lin; T-S Chiueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-18       Impact factor: 3.267

10.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.